<DOC>
	<DOCNO>NCT02302872</DOCNO>
	<brief_summary>The objective study evaluate safety performance ARTO System patient mitral valve regurgitation ( MR ) associate congestive heart failure ( CHF ) .</brief_summary>
	<brief_title>Treatment Heart Failure Associated Functional Mitral Valve Regurgitation</brief_title>
	<detailed_description />
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>1 . Is ambulatory , able willing comply study protocol provide write informed consent 2 . Age ≥ 18 3 . Transseptal catheterization determine feasible treat physician 4 . NYHA class IIIV heart failure etiology 5 . Symptomatic MR grade ≥ 2+ 6 . LVEF ≥20 % ≤ 50 % 7 . LVEDD &gt; 50 mm ≤ 70 mm 8 . No anticipated change patient 's cardiac medication regimen anticipate throughout course study . 9 . In opinion investigator , use ARTO System technically feasible clinically indicate 1 . In opinion Investigator , femoral vein internal jugular vein accommodate 16 F catheter presence inferior vena cava ( IVC ) filter would interfere advancement catheter ipsilateral DVT present 2 . Significant structural abnormality mitral valve ( e.g. , flail , prolapse , leaflet calcification ) 3 . Significant mitral annular calcification 4 . Hemodynamic instability ( systolic pressure &lt; 90 mmHg without afterload reduction cardiogenic shock need inotropic support intraaortic balloon pump ) 5 . Prior mitral valve surgery valvuloplasty currently implant prosthetic valve VAD 6 . History , active , rheumatic heart disease 7 . History Atrial Septal Defects ( ASD ) , whether repair 8 . History previously repair PFO PFO associate clinical symptom ( e.g. , cerebral ischemia ) within 6 month plan investigational procedure 9 . In opinion investigator , atrial septal aneurysm present may interfere transseptal cross 10 . Biventricular pacing initiate anticipate within 6 month plan investigational procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>